Mesenchymal Stem Cells for the Treatment of MS

NCT00781872 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: Injection of autologous bone marrow derived mesenchymal stem cells

Sponsor

Hadassah Medical Organization